Tharimmune (THAR) Institutional Ownership $2.07 -0.03 (-1.43%) (As of 12/20/2024 05:30 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Tharimmune (NASDAQ:THAR)CurrentInstitutional OwnershipPercentage1.16%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$58.58KNumber ofInstitutional Sellers(last 12 months)0 Get THAR Insider Trade Alerts Want to know when executives and insiders are buying or selling Tharimmune stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Tharimmune Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/6/2024 Curi RMB Capital LLC23,620$59K0.0%N/A2.056% (Data available from 1/1/2016 forward) THAR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of THAR shares? During the previous two years, the following institutional investors and hedge funds held shares of Tharimmune shares: Curi RMB Capital LLC ($59K).Learn more on THAR's institutional investors. What percentage of Tharimmune stock is owned by institutional investors? 1.16% of Tharimmune stock is owned by institutional investors. Learn more on THAR's institutional investor holdings. Which institutional investors have been buying Tharimmune stock? The following institutional investors have purchased Tharimmune stock in the last 24 months: Curi RMB Capital LLC ($23.62K). How much institutional buying is happening at Tharimmune? Institutional investors have bought a total of 23,620 shares in the last 24 months. This purchase volume represents approximately $58.58K in transactions. Related Companies Aspira Women's Health Institutional Ownership ImmunoPrecise Antibodies Institutional Ownership CervoMed Institutional Ownership Relmada Therapeutics Institutional Ownership Talphera Institutional Ownership Kazia Therapeutics Institutional Ownership Turnstone Biologics Institutional Ownership Sensei Biotherapeutics Institutional Ownership Jaguar Health Institutional Ownership Kiora Pharmaceuticals Institutional Ownership This page (NASDAQ:THAR) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tharimmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tharimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
